In this paper a patient with primary multiple extradural hydatid disease is described. He had no neurological deficits, although there were numerous hydatid cysts located at the thoracic 7-9 level extradurally. Nuclear magnetic resonance (NMR) was used for what would appear to be the first time for the diagnosis of spinal hydatid disease.
Introduction
Hydatid disease occurs in humans from the contamination of water and foodstuffs.1.2 It rarely affects the bones: 0.5-2% of all cases of hydatidosis.3,4 The spine is involved in 44% . The disease is seldom seen in devel oped countries, but may occur in various countries including Turkey, where it is the cause of spinal cord compression in 3.8% .3.5 According to Arana-Iniguez and Lopez Fernandez the incidence of hydatid disease of the vertebral column is 8.5% .6 It mostly affects the lumbar, thoracic and cervical regions respectively 7 and begins as a single primary cyst which contains daughter cysts. Rupture of a cyst into the muscles may be followed by secondary hydatid cysts. Some times these may be forced by muscle move ments some distance along the vertebral column or in the connective tissue planes, similar to what occurred in our patient. 8
Case report
A forty year old farmer was transferred from the Social Security Hospital to the outpatient department of our clinic with a 6-month history of back pain and a subcu taneous mass in the upper thoracic region. The mass was totally excised in that hospital and the pathology study showed it to be a clinical examination showed a 3 x 5 cm fluc tuant subcutaneous mass at the TS-6 level, on palpation, laterally on the left side; and a 1 x 2 cm subcutaneous mass was palpated 10 cm laterally on the right side. The neuro logical examination was totally normal, as was the routine laboratory examination. Plain x-rays of the spine showed minimal erosion of the T7 lamina. Plain x-rays of the lung were normal, and abdominal ultraso nography was normal. The NMR examina tion revealed numerous cysts located ex tradurally all along the vertebrae at T7-9 level and subcutaneous cysts were located bilaterally at T3 level (Figs 1 and 2 ). An operation was carried out, and a 3 x 5 cm infected subcutaneous cyst was excised at the T3 level on the left lateral aspect and another measuring 2 x 1 cm, an infected subcutaneous cyst, was excised on the right lateral side. Multiple cysts were located and removed paravertebrally. A T7 -9 laminec tomy was performed and multiple cysts were seen in an extra pouch located right ex tradural laterally and were grossly removed (Fig 3) . The operation area was soaked with 3% NaCl wetted patties for a few minutes, which were then removed and the area was washed with normal 0.09% NaCl. After the operation the neurological examination re mained normal. The patient was given mebendazole orally for one year, without any side effects.
Discussion
The incidence of vertebral hydatid disease is less than hepatic and pulmonary involve ment. Primary vertebral hydatid disease without any other systemic involvement can occur if there are direct porto-vertebral venous shunts.9 In the literature one-third Figure 3 Multiple cysts seen during operation.
of the patients had previously undergone surgery for their cystS.5 Our patient had a history of cyst resection, and coincidentally hydatid disease was diagnosed. Further in vestigations were then made to obtain the exact site( s) of the lesion( s). In the literature all of the patients had neurological disturbances3 -5. canal, and thus reveal the full spinal extent of the disease. We are unaware of any other NMR study of hydatid cyst disease prev iously reported. This is the first study to be reported, and it shows that in complicated clinical situations the exact level cannot be precisely defined, though NMR is most helpful. It also demonstrates the cyst con tents, including daughter scolices and hy datid sand.2 Surgical extirpation is the only possible treatment for spinal hydatid disease as there is a great risk of spinal cord compression. The benzimidazole derivative mebendazole has a known lethal effect on secondary E Granulosis cysts;9 thus it can be used in the pre, peri and postoperative periods.
